Festive celebrations are an important part of the winter holiday season. From parties to feasts to opening presents, many cherished holiday traditions have one thing in common – gathering with friends and family. Taking precautions to help keep loved ones safe from COVID-19 should be an important part of your plan this year, especially with […]
Author Archives: katie carrera
13
Dec
Dec
This December, BioReference is proud to be celebrating an exciting milestone – our 40th anniversary. For over four decades, our dedicated team has worked to build a legacy of scientific expertise through innovative and tailored laboratory test solutions. Join us in celebrating our 40th anniversary and learn more about our dynamic evolution. BioReference Celebrates 40 […]
08
Dec
Dec
MIAMI, Dec. 08, 2021 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) today announced that the U.S. Food and Drug Administration (FDA) has approved OPKO’s 4Kscore Test. This test is approved for use in men age 45 and older who have not had a prior prostate biopsy or are biopsy negative and have an age-specific abnormal total PSA and/or […]
In case you missed it: Richard Schwabacher, Senior Vice President, Digital Health and Chief Digital Officer, was named a Corporate Finalist for the New York CIO of the Year, for the CIO ORBIE Awards 2021. Skip to the 1:50 mark in the Corporate Finalist video to hear Richard discuss digital transformation and use of technology […]
02
Dec
Dec
As you may have seen in the news, a new variant of SARS-CoV-2, B.1.1.529, has been classified by the World Health Organization (WHO).1 Named “Omicron,” this variant of concern was first reported in South Africa on November 24, 2021.1 With the first case of this variant in the United States confirmed on December 1, 2021,2 […]
Press Release
BioReference Laboratories Announces Readiness for COVID-19 Testing if the Omicron COVID-19 Variant Emerges in The U.S.
29
Nov
Nov
ELMWOOD PARK, N.J., November 29, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), announced COVID-19 testing preparedness for the Omicron Variant. BioReference’s PCR diagnostic tests for SARS-CoV-2 COVID-19 are based on recognizing specific RNA target genes that are common to all coronaviruses. To date, the diagnostic targets have not changed with the novel […]
29
Nov
Nov
According to the Centers for Disease Control and Prevention (CDC), outdoor activities are still safer to take part in than indoor activities due to COVID-19.1 Though, with chilly weather settling in in many regions, this may mean changing some of our go-to adventures. Luckily, fall and winter bring a host of new opportunities to enjoy […]
23
Nov
Nov
Thanksgiving brings the beginning of the winter holiday season – a time for connection and celebration. As family gathers around the table to give thanks, a toast to health is often in order. This year, take the opportunity to touch base with your loved ones about important familial health matters like cancer screening for hereditary […]
19
Nov
Nov
BioReference has been providing COVID-19 testing for sports fans since early 2021 when the Buffalo Bills hosted the Wild Card game in January. It was the first time fans had been welcomed in the stadium since the pandemic began, and testing was mandatory in order to attend. Since then, BioReference has provided countless COVID-19 fan […]
15
Nov
Nov
As the weather cools and the leaves continue to change, it’s time again to start preparing for cold and flu season. However, with COVID-19 still a pressing issue, and winter allergies emerging, it can often be tough to decipher between illnesses when you feel like you might be coming down with something. Here, we’re breaking […]
